Literature DB >> 7035568

An enzymatic method for preparation of dissociated murine Peyer's patch cells enriched for macrophages.

M V Frangakis, W J Koopman, H Kiyono, S M Michalek, J R McGhee.   

Abstract

Enzyme (Dispase) dissociation of murine Peyer's patches (PP) 3 yields a cell population rich in T and B lymphocytes and containing 5-9% macrophages (MO) as defined by morphology and esterase staining. Cell yields by this method are 3-4 times greater than with conventional mechanical methods and viability of cells always exceeds 95%. The virtual absence of IgA plasma cells (less than 1%) indicates lack of contamination of the cell preparations with intestinal mucosal cells. Enzymatically dissociated PP cells proliferate in response to both T and B cell mitogens. Differences in patterns of mitogen responsiveness of sequentially obtained PP cell fractions are observed suggesting considerable functional heterogeneity of PP cells. Patterns of IgM and IgA synthesis by PP cells in response to the B cell polyclonal activator LPS differ considerably from spleen cells. The development of methodology for preparation of PP cells containing functionally intact T and B cells and enriched for MO should permit analysis of the cellular basis for functional specialization of PP.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7035568     DOI: 10.1016/0022-1759(82)90207-1

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  26 in total

1.  Cellular origins of human polymeric and monomeric IgA: enumeration of single cells secreting polymeric IgA1 and IgA2 in peripheral blood, bone marrow, spleen, gingiva and synovial tissue.

Authors:  A Tarkowski; Z Moldoveanu; W J Koopman; J Radl; J J Haaijman; J Mestecky
Journal:  Clin Exp Immunol       Date:  1991-08       Impact factor: 4.330

2.  Ro/SS-A-reactive B lymphocytes in salivary glands and peripheral blood of patients with Sjögren's syndrome.

Authors:  A Halse; J B Harley; U Kroneld; R Jonsson
Journal:  Clin Exp Immunol       Date:  1999-01       Impact factor: 4.330

3.  Preparation of interstitial lung cells by enzymatic digestion of tissue slices: preliminary characterization by morphology and performance in functional assays.

Authors:  P G Holt; A Degebrodt; T Venaille; C O'Leary; K Krska; J Flexman; H Farrell; G Shellam; P Young; J Penhale
Journal:  Immunology       Date:  1985-01       Impact factor: 7.397

4.  Membrane and functional characterization of lymphoid and macrophage populations of Peyer's patches from adult and aged mice.

Authors:  V Vĕtvicka; H Tlaskalová-Hogenová; L Fornůsek; B Ríhová; V Holán
Journal:  Immunology       Date:  1987-09       Impact factor: 7.397

5.  Influence of ofloxacin on murine Peyer's patch lymphocytes.

Authors:  C De Simone; S Zanzoglu; G Santini; M Ciardi; S Delia; F Sorice
Journal:  Infection       Date:  1986       Impact factor: 3.553

6.  Preparation, purification and characterization of bovine Peyer's patch leukocytes.

Authors:  A M Nagi; L A Babiuk
Journal:  Can J Vet Res       Date:  1988-04       Impact factor: 1.310

7.  Fetal calf serum stimulates 'autoreactive' T-cell hybridomas.

Authors:  A M Pullen; A J Munro
Journal:  Immunology       Date:  1988-02       Impact factor: 7.397

8.  Immunobiology of the oral mucosa in the mouse.

Authors:  N Deslauriers; S Néron; W Mourad
Journal:  Immunology       Date:  1985-07       Impact factor: 7.397

9.  Lactoferrin causes IgA and IgG2b isotype switching through betaglycan binding and activation of canonical TGF-β signaling.

Authors:  Y-S Jang; G-Y Seo; J-M Lee; H-Y Seo; H-J Han; S-J Kim; B-R Jin; H-J Kim; S-R Park; K-J Rhee; W-S Kim; P-H Kim
Journal:  Mucosal Immunol       Date:  2014-12-10       Impact factor: 7.313

10.  Intestinal immune responses in humans. Oral cholera vaccination induces strong intestinal antibody responses and interferon-gamma production and evokes local immunological memory.

Authors:  M Quiding; I Nordström; A Kilander; G Andersson; L A Hanson; J Holmgren; C Czerkinsky
Journal:  J Clin Invest       Date:  1991-07       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.